Humana, Inc. Hits New 52-Week High at $372.49, Reflecting Strong Growth

Humana, Inc., a prominent player in the healthcare services industry, has reached a significant milestone by hitting a new 52-week high of USD 372.49 on June 11, 2026. This achievement underscores the company's robust market position within the mid-cap sector, where it boasts a market capitalization of USD 32,156 million. Over the past year, Humana's stock performance has shown a gain of 5.54%, although it trails behind the S&P 500's performance of 22.78%. The company's price-to-earnings (P/E) ratio stands at 27.00, indicating its valuation relative to earnings. Additionally, Humana offers a dividend yield of 1.60%, providing a return to its shareholders. Financial metrics reveal a debt-to-equity ratio of -0.42, suggesting a strong balance sheet, while a return on equity of 6.81% reflects the company's efficiency in generating profits from its equity. The price-to-book ratio is recorded at 1.82, further illustrating the company's valuation in relation to its assets. Overall, Humana's recent performance highlights its resilience and strategic positioning in the competitive healthcare services landscape.